In lupus nephritis, the benefit of rituximab monotherapy,...

In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: Comment on the article by Sfikakis et al

Ronald van Vollenhoven, Iva Gunnarsson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
52
Year:
2005
Language:
english
Pages:
2
DOI:
10.1002/art.21610
File:
PDF, 41 KB
english, 2005
Conversion to is in progress
Conversion to is failed